Developing models to understand infectious diseases
Official title: Pre-Clinical Models of Infectious Diseases
Funded at Institute for Clinical Pharmacodynamics · NIH-11197704 · Data updated 2026-11-12
This study is working on creating models that mimic infectious diseases to help researchers find better treatments, which could lead to new options for patients in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Institute for Clinical Pharmacodynamics NIH-funded |
| Lab location | 1 site (Schenectady, UNITED STATES) |
| Project start | July 15, 2024 |
| Project end | July 14, 2031 |
| Funding year | 2024 |
| Award (this year) | $2,500 |
| NIH project number | 75N93024D00013-0-759302400001-1 |
| Project ID | NIH-11197704 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research would include individuals at risk of infectious diseases or those who may benefit from new therapeutic approaches.
✕Less likely to help
Patients with established infectious diseases who are not eligible for new treatment modalities may not receive direct benefits from this research.
What this research studies
This research focuses on creating pre-clinical models that simulate infectious diseases to better understand their mechanisms and potential treatments. By using these models, researchers aim to evaluate the effectiveness of medical countermeasures before they are tested in humans. Patients may benefit from advancements in treatment options that arise from these models, as they help identify promising therapies and interventions. The approach involves rigorous testing and development of reagents and methodologies to ensure accurate representation of infectious disease dynamics.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and preventive measures for infectious diseases.
How similar studies have gone: Other research has shown success in developing pre-clinical models for infectious diseases, indicating that this approach is both tested and promising.
Where this research is happening
-
Institute for Clinical Pharmacodynamics
Schenectady, United States Active
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.